Cargando…

Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer

BACKGROUND: The role of calcineurin/NFAT signaling in ovarian cancer has been unknown. NFAT was significantly overexpressed in ovarian cancer tissues and that overexpression of NFAT was significantly associated with metastasis and poor prognosis on clinical tissue level. To investigate whether NFAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Bing, Ji, Kai-Qiang, Liu, Yi-Si, Zhao, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688357/
https://www.ncbi.nlm.nih.gov/pubmed/31399054
http://dx.doi.org/10.1186/s13048-019-0550-0
_version_ 1783442873014812672
author Xin, Bing
Ji, Kai-Qiang
Liu, Yi-Si
Zhao, Xiao-Dong
author_facet Xin, Bing
Ji, Kai-Qiang
Liu, Yi-Si
Zhao, Xiao-Dong
author_sort Xin, Bing
collection PubMed
description BACKGROUND: The role of calcineurin/NFAT signaling in ovarian cancer has been unknown. NFAT was significantly overexpressed in ovarian cancer tissues and that overexpression of NFAT was significantly associated with metastasis and poor prognosis on clinical tissue level. To investigate whether NFAT upstream protein, calcineurin (CN), affects the prognosis in various histological subtype of ovarian cancer (OC). METHODS: The association between CN and clinical features was analyzed in 50 OC patients treated from 2007 to 2012. CN expression was examined using immunohistochemistry. We observed the association of CN expression with the prognosis in these patients. RESULTS: CN expression was significantly increased in later-stage tumor tissue of serous carcinoma compared with those with early-stage. The expression of CN positively correlated with the serum cancer antigen 125 (CA125) level in ovarian clear-cell carcinoma and the serum alpha-fetoprotein (AFP) level in papillary serous cystadenocarcinoma. Particularly, higher CN expression in tumor tissues significantly correlated with reduced overall survival among patients with serous carcinoma. In addition, the serum cancer antigen 72–4 (CA72–4) level, serum carcinoembryonic antigen (CEA) levels, pathological stage, lymph node metastasis, and chemotherapeutic resistance were identified as significant prognostic factors in ovarian clear-cell carcinoma, serous carcinoma, or papillary serous cystadenocarcinoma. CONCLUSIONS: CN is upregulated in ovarian cancer tissues with later-stage and that the expression of CN, CA72–4, and CEA was remarkably associated with poor prognosis in unique subtype of ovarian cancer. CN levels may be investigated for use as a prognostic biomarker for risk assessment in unique subtype of OC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13048-019-0550-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6688357
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66883572019-08-14 Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer Xin, Bing Ji, Kai-Qiang Liu, Yi-Si Zhao, Xiao-Dong J Ovarian Res Research BACKGROUND: The role of calcineurin/NFAT signaling in ovarian cancer has been unknown. NFAT was significantly overexpressed in ovarian cancer tissues and that overexpression of NFAT was significantly associated with metastasis and poor prognosis on clinical tissue level. To investigate whether NFAT upstream protein, calcineurin (CN), affects the prognosis in various histological subtype of ovarian cancer (OC). METHODS: The association between CN and clinical features was analyzed in 50 OC patients treated from 2007 to 2012. CN expression was examined using immunohistochemistry. We observed the association of CN expression with the prognosis in these patients. RESULTS: CN expression was significantly increased in later-stage tumor tissue of serous carcinoma compared with those with early-stage. The expression of CN positively correlated with the serum cancer antigen 125 (CA125) level in ovarian clear-cell carcinoma and the serum alpha-fetoprotein (AFP) level in papillary serous cystadenocarcinoma. Particularly, higher CN expression in tumor tissues significantly correlated with reduced overall survival among patients with serous carcinoma. In addition, the serum cancer antigen 72–4 (CA72–4) level, serum carcinoembryonic antigen (CEA) levels, pathological stage, lymph node metastasis, and chemotherapeutic resistance were identified as significant prognostic factors in ovarian clear-cell carcinoma, serous carcinoma, or papillary serous cystadenocarcinoma. CONCLUSIONS: CN is upregulated in ovarian cancer tissues with later-stage and that the expression of CN, CA72–4, and CEA was remarkably associated with poor prognosis in unique subtype of ovarian cancer. CN levels may be investigated for use as a prognostic biomarker for risk assessment in unique subtype of OC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13048-019-0550-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-09 /pmc/articles/PMC6688357/ /pubmed/31399054 http://dx.doi.org/10.1186/s13048-019-0550-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xin, Bing
Ji, Kai-Qiang
Liu, Yi-Si
Zhao, Xiao-Dong
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title_full Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title_fullStr Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title_full_unstemmed Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title_short Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
title_sort higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688357/
https://www.ncbi.nlm.nih.gov/pubmed/31399054
http://dx.doi.org/10.1186/s13048-019-0550-0
work_keys_str_mv AT xinbing higherexpressionofcalcineurinpredictspoorprognosisinuniquesubtypeofovariancancer
AT jikaiqiang higherexpressionofcalcineurinpredictspoorprognosisinuniquesubtypeofovariancancer
AT liuyisi higherexpressionofcalcineurinpredictspoorprognosisinuniquesubtypeofovariancancer
AT zhaoxiaodong higherexpressionofcalcineurinpredictspoorprognosisinuniquesubtypeofovariancancer